346 related articles for article (PubMed ID: 6347368)
1. Serological demonstration of an allogeneic Ia.7 antigen on the cell surface of SJL/J-derived reticulum cell sarcomas.
Wilbur SM; Marelli O; Bonavida B
Cancer Res; 1983 Sep; 43(9):4266-70. PubMed ID: 6347368
[TBL] [Abstract][Full Text] [Related]
2. Mapping of SJL/J reticulum cell sarcoma tumor-associated Ia antigens by T cell hybridomas: characterization of tumor-specific and shared epitopes detected on IE+ allogeneic cells.
Ohnishi K; Bonavida B
J Immunol; 1986 Jul; 137(2):733-40. PubMed ID: 2424977
[TBL] [Abstract][Full Text] [Related]
3. Specific lymphocyte-target cell conjugate formation between tumor-specific helper T-cell hybridomas and IA-bearing RCS tumors and IE-bearing allogeneic cells. I. Role of Ia and both L3T4 and LFA-1 antigens in recognition/binding.
Ohnishi K; Bonavida B
J Immunol; 1986 Dec; 137(11):3681-8. PubMed ID: 2946766
[TBL] [Abstract][Full Text] [Related]
4. Inappropriate alloantigen-like specificities detected on reticulum cell sarcomas of SJL/J mice: characterization and biologic role.
Bonavida B; Roman JM; Hutchinson IV
Transplant Proc; 1980 Mar; 12(1):59-64. PubMed ID: 6154360
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the molecules on SJL/J lymphomas which stimulate syngeneic T cells.
Brown PH; Thorbecke GJ
J Immunol; 1985 Nov; 135(5):3572-80. PubMed ID: 3900211
[TBL] [Abstract][Full Text] [Related]
6. Characterization of SJL T cell clones responsive to syngeneic lymphoma (RCS): RCS-specific clones are stimulated by activated B cells.
DeKruyff RH; Brown PH; Thorbecke GJ; Ponzio NM
J Immunol; 1985 Nov; 135(5):3581-6. PubMed ID: 2413126
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Ia+ reticulum cell sarcoma (RCS) growth in syngeneic SJL/J mice. I. Inhibition of tumor growth by passive administration of L3T4 monoclonal antibody before or after tumor inoculation.
Ohnishi K; Bonavida B
J Immunol; 1987 Jun; 138(12):4524-9. PubMed ID: 2953807
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of IA positive reticulum cell sarcoma tumor cell growth in syngeneic SJL/J mice by passive administration of monoclonal anti-IA antibody.
Sakano T; Bonavida B
Cancer Res; 1986 Jul; 46(7):3245-8. PubMed ID: 3518916
[TBL] [Abstract][Full Text] [Related]
9. Expression of hybrid Ia molecules on the cell surface of reticulum cell sarcomas that are undetectable on host SJL/J lymphocytes.
Wilbur SM; Bonavida B
J Exp Med; 1981 Mar; 153(3):501-13. PubMed ID: 6166700
[TBL] [Abstract][Full Text] [Related]
10. Ia-restricted interaction of normal lymphoid cells and SJL lymphoma (reticulum cell sarcoma) leading to lymphokine production. II. Rapid production of antibody-enhancing factor, interleukin 2, and immune interferon.
Ponzio NM; Hayama T; Nagler C; Katz IR; Hoffmann MK; Gilbert K; Vilcek J; Thorbecke GJ
J Natl Cancer Inst; 1984 Feb; 72(2):311-20. PubMed ID: 6420599
[TBL] [Abstract][Full Text] [Related]
11. The in vivo depletion of V beta 17a+ T cells results in the inhibition of reticulum cell sarcoma growth in SJL/J mice. Evidence for the use of anticlonotypic antibody therapy in the control of malignancy.
Katz JD; Lebow LT; Bonavida B
J Immunol; 1989 Aug; 143(4):1387-95. PubMed ID: 2663994
[TBL] [Abstract][Full Text] [Related]
12. Properties of reticulum cell sarcomas in SJL/J mice. VIII. Prominent role of RCS cell I-A antigens in the stimulation of syngeneic T cells.
Brown PH; Mathis D; Cone RE; Jones PP; Ponzio NM; Thorbecke GJ
Immunogenetics; 1983; 18(4):399-413. PubMed ID: 6226603
[TBL] [Abstract][Full Text] [Related]
13. Syngeneic response to SJL follicular center B cell lymphoma (reticular cell sarcoma) cells is primarily in V beta 16+ CD4+ T cells.
Tsiagbe VK; Asakawa J; Miranda A; Sutherland RM; Paterson Y; Thorbecke GJ
J Immunol; 1993 Jun; 150(12):5519-28. PubMed ID: 8099938
[TBL] [Abstract][Full Text] [Related]
14. Molecular evidence that SJL reticulum cell sarcomas are derived from pre-B cell. Clonal rearrangement of heavy chain but not of light chain immunoglobulin genes.
Nakauchi H; Osada H; Yagita H; Okumura K
J Immunol; 1987 Oct; 139(8):2803-9. PubMed ID: 3116094
[TBL] [Abstract][Full Text] [Related]
15. Characterization and growth factor requirements of SJL lymphomas. I. Development of a B cell growth factor-dependent in vitro cell line, cRCS-X.
Lasky JL; Ponzio NM; Thorbecke GJ
J Immunol; 1988 Jan; 140(2):679-87. PubMed ID: 3275720
[TBL] [Abstract][Full Text] [Related]
16. Similarities between the syngeneic mixed lymphocyte response and lymphoma-induced T cell proliferation in SJL/J mice.
Ponzio NM
Behring Inst Mitt; 1983 May; (72):28-36. PubMed ID: 6085747
[TBL] [Abstract][Full Text] [Related]
17. Properties of reticulum cell sarcomas in SJL/J mice. V. Nature of reticulum cell sarcoma surface antigen which induces proliferation of normal SJL/J T cells.
Ponzio NM; David CS; Shreffler DC; Thorbecke GJ
J Exp Med; 1977 Jul; 146(1):132-145. PubMed ID: 68988
[TBL] [Abstract][Full Text] [Related]
18. Ia-restricted interaction of normal lymphoid cells and SJL lymphoma (reticulum cell sarcoma) leading to lymphokine production. III. Relative roles of reticulum cell sarcoma and normal lymphoid cells in lymphokine production.
Hayama T; Ponzio NM; Nagler C; Vilcek J; Coico RF; Thorbecke GJ
J Natl Cancer Inst; 1984 Feb; 72(2):321-31. PubMed ID: 6420600
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cell activity in reticulum-cell sarcomas of SJL/J mice. II. Analysis of RCS-associated NK activity.
Fitzgerald KL; Ponzio NM
Int J Cancer; 1981 Nov; 28(5):627-34. PubMed ID: 6171532
[TBL] [Abstract][Full Text] [Related]
20. A spontaneous sarcoma dependent on host tumor-specific immune lymphocytes.
Katz JD; Bonavida B
Bioessays; 1989 Dec; 11(6):181-5. PubMed ID: 2695084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
